Elahe Shenasa

1PUBLICATIONS
4CO-AUTHORS
Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 12, 2022
Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial.

Elahe Shenasa, Elisabeth Specht Stovgaard, Maj-Britt Jensen

Pageof 1

Frequent Collaborators

1 joint publications

Elisabeth Specht Stovgaard

1 joint publications

Karama Asleh

1 joint publications

Samuel Leung

1 joint publications

Bent Ejlertsen